Tilray, a Canadian supplier of medical cannabis, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.
The British Columbia, Canada-based company booked $23 million in sales for the 12 months ended March 31, 2018. It plans to list on the Nasdaq under the symbol TLRY. Tilray filed confidentially on March 19, 2018. Cowen & Company is the sole bookrunner on the deal. No pricing terms were disclosed.
